[T]he Senate Appropriations Committee
voted by voice vote to approve an amendment that would block the
Department of Justice from spending any funds to undermine state medical
marijuana laws. The amendment – led by Senator Leahy (D-VT) – is a
striking rebuke of Attorney General Jeff Sessions, who had personally requested
that Congress eliminate the amendment and allow him to prosecute
medical marijuana providers and patients.
The amendment passed with
strong Republican support, a sign that Sessions is isolated politically
as rumors of a crackdown on marijuana businesses abound.
The attorney general is an ardent supporter of the ruinous decades-long war on drugs, which has resulted in innumerable destroyed lives in the US. The militarization of the so-called war has also led to the deaths of untold numbers of people in Mexico and Latin America.
However, many countries continue to move away from war-on-drugs politics. Contrast the Trump Department of Justice's return to failed anti-drug policies with what occurred in Uruguay this week. It became the first nation in the world to begin the countrywide retail sale of marijuana on July 19.
According to the HuffPo,
[Last] Wednesday, Uruguay began sales of legal marijuana for adult residents....
Uruguay’s model will look quite different
from the eight U.S. states that have legalized marijuana. Since there
is no one-size-fits-all marijuana legalization system, it’s important
for each jurisdiction to tailor marijuana regulation to their local
needs and contexts, providing the world with different models to learn
from.
The Uruguayan model allows four forms of
access to marijuana: medical marijuana through the Ministry of Public
Health; domestic cultivation of up to six plants per household;
membership clubs where up to 45 members can collectively produce up to
99 plants; and licensed sale in pharmacies to adult residents.
Regulation will be overseen by the government’s Institute for the
Regulation and Control of Cannabis (IRCCA).
This is a historic moment. In recent
years, Latin American leaders have decried the staggering human,
environmental and financial costs of the war on drugs in their region.
Uruguay is boldly demonstrating that concrete alternatives to failed
prohibitionist policies are possible.
Marijuana reform
gained remarkable momentum throughout the hemisphere in recent years.
Twenty-nine U.S. states have legalized medical marijuana, while eight
states and Washington D.C. have legalized marijuana more broadly. Jamaica decriminalized marijuana for medical, scientific and religious purposes; Colombia and Puerto Rico legalized medical marijuana through executive orders; Chile allows for marijuana cultivation for oncology patients; Mexico
recently passed a medical marijuana bill a year after their Supreme
Court ruled that prohibition of marijuana for personal consumption is
unconstitutional; and Canada is set to become the next country to fully legalize marijuana.
The only hope is that a pending DOJ task force study due out soon will conclude that marijuana use is not associated with increasing crime, as Sessions has personally contended.
The US already has the largest prison population in the world, yet we are now saddled with an executive branch that is determined to boost the size of the prison-industrial complex and pursue more failed policies. The damage done by this approach does direct harm to people, particularly people of color, while many others financially benefit from the growth of the mass-incarceration industry.
In an article about the commencement of retail marijuana sales in Uruguay, The New York Times notes,
The government limits how much people can
buy each week. And in an effort to undercut drug traffickers, it is
setting the price below black market rates, charging roughly $13 dollars
for 10 grams, enough for about
15 joints, advocates say. The law also bars advertising and sets aside a
percentage of proceeds from commercial sales to pay for addiction
treatment and public awareness campaigns about the risks of drug use.
“These are measures designed to help
people who are already users without encouraging others who don’t
consume,” said Alejandro Antalich, the vice president of the Center of
Pharmacies in Uruguay, an industry group. “If this works as planned,
other countries could adopt it as a model.”
No comments:
Post a Comment